For NK cell activation,
IL-12p70 and
IL-18 were purchased from Peprotech (Rocky Hill, NJ) and MBL International (Woburn, MA), respectively.
IL-15-amplified NK cells were stimulated for 18 h with 1.3 nM
IL-12 and 22.2 nM
IL-18 in optimized NK cell medium. As a non-activated control, a portion of NK cells were incubated with 50 nM
IL-15 in optimized NK cell medium. After overnight stimulation, a small sample of supernatant was removed from both
IL-12/18 and
IL-15 cultures and IFN-γ levels were quantitated by xMAP cytokine bead array (EMD Millipore, Billerica, MA) using a
BioPlex 200 Array Reader (Bio-Rad, Hercules, CA). NK cells were washed with 2x 50 ml portions of PBS and resuspended to a final concentration of 1–1.5x10
7 cells/ml in PBS + 0.05% BSA. Groups of CAST/EiJ were inoculated IP with 3–3.5x10
6 cells in 0.2 ml.
For NK cell-labeling experiments,
IL-12/
IL-18 activated NK cells were washed 2x with 50 ml of PBS and resuspended to a final concentration of 5x10
6 cells/ml in 1 μM
CFSE (Thermo Fisher Scientific, Waltham, MA) in PBS. After staining for 10 min in the dark at room temperature,
CFSE labeling was quenched by addition of ice-cold cRPMI. Cells were washed with 50 ml of PBS and resuspended to a final concentration of 1–1.5x10
7 cells/ml in PBS + 0.05% BSA. Groups of CAST/EiJ were inoculated IV with 2-3x10
6 cells in 0.2 ml.
Earl P.L., Americo J.L, & Moss B. (2020). Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses. PLoS Pathogens, 16(4), e1008505.